Further analysis of the tumor lysates indicated that V-Navo@gel could elevate pro-inflammation cytokines (IL12 and IFNγ) and granzyme B, the marker of activated T cells, at the tumor site (Fig. 7f), indicating the elevated anti-tumor immune responses against tumors. The gene discussed is IFNG; the disease is neoplasm.